Shavonn Harper

Shavonn Harper has a diverse work experience spanning multiple roles and industries. Shavonn began their career as a Teaching Assistant for the Genetics Laboratory at Ursinus College in 2011, followed by an internship at Merck in 2011. In 2012, they were a Graduate Student at Temple University School of Medicine, where they likely focused on their studies in the field of medical research.

Shavonn then served as a Supplemental Instructor for Cell Biology at Ursinus College in 2012 before transitioning to a Postdoctoral Fellow position at Temple University - Lewis Katz School of Medicine in 2018. As a Postdoctoral Fellow, Shavonn focused on studying the role of GRK5 as an epigenetic modulator in the heart, with an emphasis on its contribution to cardiac hypertrophy. Shavonn also explored potential sex differences in the development of cardiac hypertrophy related to GRK5.

In 2020, Shavonn became a Scientific Communications Manager at AlphaBioCom, where they likely utilized their expertise in medical research to oversee the development of scientific communication materials. Shavonn then joined Prime Global in 2021 as a Medical Writer, further honing their skills in medical writing.

Most recently, in 2022, Shavonn joined The Curry Rockefeller Group, LLC as a Senior Medical Writer. With their extensive experience and expertise in medical research and writing, Shavonn is well-equipped to contribute to the team's medical writing projects.

Shavonn Harper attended Ursinus College from 2008 to 2012, where they pursued a Bachelor of Science (B.S.) degree. Shavonn completed a double major in Biology and Media and Communications during their time there. Following this, they enrolled at Temple University - Lewis Katz School of Medicine from 2012 to 2018. Shavonn obtained a Doctor of Philosophy (PhD) degree in Biomedical Science, with a focus on Cardiovascular Research from Temple University.